208 related articles for article (PubMed ID: 29367259)
1. Pharmacogenomics of Chemically Distinct Classes of Keap1-Nrf2 Activators Identify Common and Unique Gene, Protein, and Pathway Responses In Vivo.
Wible RS; Tran QT; Fathima S; Sutter CH; Kensler TW; Sutter TR
Mol Pharmacol; 2018 Apr; 93(4):297-308. PubMed ID: 29367259
[TBL] [Abstract][Full Text] [Related]
2. Genetic versus chemoprotective activation of Nrf2 signaling: overlapping yet distinct gene expression profiles between Keap1 knockout and triterpenoid-treated mice.
Yates MS; Tran QT; Dolan PM; Osburn WO; Shin S; McCulloch CC; Silkworth JB; Taguchi K; Yamamoto M; Williams CR; Liby KT; Sporn MB; Sutter TR; Kensler TW
Carcinogenesis; 2009 Jun; 30(6):1024-31. PubMed ID: 19386581
[TBL] [Abstract][Full Text] [Related]
3. Genetic or pharmacologic amplification of nrf2 signaling inhibits acute inflammatory liver injury in mice.
Osburn WO; Yates MS; Dolan PD; Chen S; Liby KT; Sporn MB; Taguchi K; Yamamoto M; Kensler TW
Toxicol Sci; 2008 Jul; 104(1):218-27. PubMed ID: 18417483
[TBL] [Abstract][Full Text] [Related]
4. Identification and quantification of the basal and inducible Nrf2-dependent proteomes in mouse liver: biochemical, pharmacological and toxicological implications.
Walsh J; Jenkins RE; Wong M; Olayanju A; Powell H; Copple I; O'Neill PM; Goldring CE; Kitteringham NR; Park BK
J Proteomics; 2014 Aug; 108(100):171-87. PubMed ID: 24859727
[TBL] [Abstract][Full Text] [Related]
5. A Point Mutation at C151 of
Gatbonton-Schwager T; Yagishita Y; Joshi T; Wakabayashi N; Srinivasan H; Suzuki T; Yamamoto M; Kensler TW
Mol Pharmacol; 2023 Aug; 104(2):51-61. PubMed ID: 37188495
[TBL] [Abstract][Full Text] [Related]
6. Potent protection against aflatoxin-induced tumorigenesis through induction of Nrf2-regulated pathways by the triterpenoid 1-[2-cyano-3-,12-dioxooleana-1,9(11)-dien-28-oyl]imidazole.
Yates MS; Kwak MK; Egner PA; Groopman JD; Bodreddigari S; Sutter TR; Baumgartner KJ; Roebuck BD; Liby KT; Yore MM; Honda T; Gribble GW; Sporn MB; Kensler TW
Cancer Res; 2006 Feb; 66(4):2488-94. PubMed ID: 16489057
[TBL] [Abstract][Full Text] [Related]
7. CDDO-Im protects from acetaminophen hepatotoxicity through induction of Nrf2-dependent genes.
Reisman SA; Buckley DB; Tanaka Y; Klaassen CD
Toxicol Appl Pharmacol; 2009 Apr; 236(1):109-14. PubMed ID: 19371629
[TBL] [Abstract][Full Text] [Related]
8. Role of Nrf2 in prevention of high-fat diet-induced obesity by synthetic triterpenoid CDDO-imidazolide.
Shin S; Wakabayashi J; Yates MS; Wakabayashi N; Dolan PM; Aja S; Liby KT; Sporn MB; Yamamoto M; Kensler TW
Eur J Pharmacol; 2009 Oct; 620(1-3):138-44. PubMed ID: 19698707
[TBL] [Abstract][Full Text] [Related]
9. Nrf2 induces fibroblast growth factor 21 in diabetic mice.
Furusawa Y; Uruno A; Yagishita Y; Higashi C; Yamamoto M
Genes Cells; 2014 Dec; 19(12):864-78. PubMed ID: 25270507
[TBL] [Abstract][Full Text] [Related]
10. Critical role of Nrf2 in oxidative stress-induced retinal ganglion cell death.
Himori N; Yamamoto K; Maruyama K; Ryu M; Taguchi K; Yamamoto M; Nakazawa T
J Neurochem; 2013 Dec; 127(5):669-80. PubMed ID: 23721546
[TBL] [Abstract][Full Text] [Related]
11. Genetic or pharmacologic activation of Nrf2 signaling fails to protect against aflatoxin genotoxicity in hypersensitive GSTA3 knockout mice.
Kensler KH; Slocum SL; Chartoumpekis DV; Dolan PM; Johnson NM; Ilic Z; Crawford DR; Sell S; Groopman JD; Kensler TW; Egner PA
Toxicol Sci; 2014 Jun; 139(2):293-300. PubMed ID: 24675090
[TBL] [Abstract][Full Text] [Related]
12. Modulation of gene expression by cancer chemopreventive dithiolethiones through the Keap1-Nrf2 pathway. Identification of novel gene clusters for cell survival.
Kwak MK; Wakabayashi N; Itoh K; Motohashi H; Yamamoto M; Kensler TW
J Biol Chem; 2003 Mar; 278(10):8135-45. PubMed ID: 12506115
[TBL] [Abstract][Full Text] [Related]
13. The triterpenoid CDDO-imidazolide ameliorates mouse liver ischemia-reperfusion injury through activating the Nrf2/HO-1 pathway enhanced autophagy.
Xu D; Chen L; Chen X; Wen Y; Yu C; Yao J; Wu H; Wang X; Xia Q; Kong X
Cell Death Dis; 2017 Aug; 8(8):e2983. PubMed ID: 28796242
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of the Nrf2 activators tBHQ and CDDO-Im on the early events of T cell activation.
Zagorski JW; Turley AE; Freeborn RA; VanDenBerg KR; Dover HE; Kardell BR; Liby KT; Rockwell CE
Biochem Pharmacol; 2018 Jan; 147():67-76. PubMed ID: 29155145
[TBL] [Abstract][Full Text] [Related]
15. The synthetic triterpenoids, CDDO and CDDO-imidazolide, are potent inducers of heme oxygenase-1 and Nrf2/ARE signaling.
Liby K; Hock T; Yore MM; Suh N; Place AE; Risingsong R; Williams CR; Royce DB; Honda T; Honda Y; Gribble GW; Hill-Kapturczak N; Agarwal A; Sporn MB
Cancer Res; 2005 Jun; 65(11):4789-98. PubMed ID: 15930299
[TBL] [Abstract][Full Text] [Related]
16. CDDO-Im exerts antidepressant-like effects via the Nrf2/ARE pathway in a rat model of post-stroke depression.
Hou X; Liu H; Ping Y; Zhang F; Zhi L; Jiang X; Zhang F; Song C; Zhang Z; Song J
Brain Res Bull; 2021 Aug; 173():74-81. PubMed ID: 33991607
[TBL] [Abstract][Full Text] [Related]
17. Bardoxolone ameliorates TGF-β1-associated renal fibrosis through Nrf2/Smad7 elevation.
Song MK; Lee JH; Ryoo IG; Lee SH; Ku SK; Kwak MK
Free Radic Biol Med; 2019 Jul; 138():33-42. PubMed ID: 31059771
[TBL] [Abstract][Full Text] [Related]
18. Pharmacodynamic characterization of chemopreventive triterpenoids as exceptionally potent inducers of Nrf2-regulated genes.
Yates MS; Tauchi M; Katsuoka F; Flanders KC; Liby KT; Honda T; Gribble GW; Johnson DA; Johnson JA; Burton NC; Guilarte TR; Yamamoto M; Sporn MB; Kensler TW
Mol Cancer Ther; 2007 Jan; 6(1):154-62. PubMed ID: 17237276
[TBL] [Abstract][Full Text] [Related]
19. The Keap1-Nrf2 system prevents onset of diabetes mellitus.
Uruno A; Furusawa Y; Yagishita Y; Fukutomi T; Muramatsu H; Negishi T; Sugawara A; Kensler TW; Yamamoto M
Mol Cell Biol; 2013 Aug; 33(15):2996-3010. PubMed ID: 23716596
[TBL] [Abstract][Full Text] [Related]
20. Dimethyl fumarate and the oleanane triterpenoids, CDDO-imidazolide and CDDO-methyl ester, both activate the Nrf2 pathway but have opposite effects in the A/J model of lung carcinogenesis.
To C; Ringelberg CS; Royce DB; Williams CR; Risingsong R; Sporn MB; Liby KT
Carcinogenesis; 2015 Jul; 36(7):769-81. PubMed ID: 25939751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
